课题基金 / 基金详情

Natural Killer Cell Cancer Immunotherapy

Natural Killer Cell Cancer Immunotherapy
自然杀伤细胞癌症免疫疗法
批准号:
nhmrc : 1195296
负责人:
金额:
$223.82万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Investigator Grants
财政年份:
2021
资助国家:
澳大利亚
项目状态:
未结题
起止时间:
2021-01-01 至 2025-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Natural killer (NK) cell posses the ability to detect and kill transformed or stressed cells such as tumour cells. My recent data show that NK cells are required for efficient immunotherapy responses by enhancing the global immune response to cancer and preventing tumour cells from metastasising to vital organs. I propose to identify novel pathways and develop new therapeutic approaches to exploit NK cell anti-tumor function and improve cancer immunotherapy response rates in patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金